SynthesisJournal of cardiothoracic surgery2026
Restrictive versus liberal red blood cell transfusion strategies for cardiac surgery: a systematic review and meta-analysis of randomized controlled trials.
Synthesis in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe equivalence of transfusion-related outcomes between restrictive and liberal red blood cell (RBC) transfusion strategies after cardiac surgery remains to be determined. This review provides an overview of the impact of restrictive RBC transfusion strategies compared with liberal transfusion strategies on the transfusion-related outcomes of postcardiac surgery patients.
methodsStudies in MEDLINE, Elsevier, Cochrane Central Register of Controlled Trials and Web of Science databases until March 2025 were searched. Studies compared the effects of restrictive RBC transfusion strategies with liberal transfusion strategies in postcardiac surgery patients were eligible. Two reviewers extracted data independently. Data including sample size, characteristics of patients, intervention and outcomes were extracted. Primary outcome was respiratory complications. Subgroup analyses were conducted by time of follow-up and Euroscore I. Review Manager 5.4 was used to evaluate the risk of bias and data. Random errors were evaluated by trial sequential analysis (TSA).
resultsOf the 4293 records identified, 13 studies compared restrictive versus liberal transfusion strategies, including 9,267 patients receiving restrictive transfusion (49.98%) and 9,275 receiving liberal transfusion (50.02%). There was no significant difference in respiratory complications between the restrictive transfusion group and the liberal transfusion group (risk ratio [RR] 1.07; 95% confidence interval [CI] 0.90–1.26; P = 0.44), but we found a statistically significant for gastrointestinal complications (RR 1.99; 95% CI 1.05–3.77; P = 0.04) and units of RBC transfusions (mean deviation [MD] -0.70; 95% CI -0.96–-0.43, P < 0.00001). Different transfusion strategies had no statistically significant effect on other transfusion-related outcomes. Subgroup analyses for mortality indicated that patients with low Euroscore I risk preferred restrictive transfusion (RR 1.72; 95% CI 1.16–2.57; P = 0.007). The TSA indicated insufficient number of trials and evidence to support firm conclusions.
conclusionsThere are no significant differences in the risk of respiratory complications between restrictive and liberal transfusion strategies. However, the restrictive transfusion strategy is associated with an increased risk of gastrointestinal complications and a lower number of RBC transfusion units in patients undergoing cardiac surgery. Additionally, restrictive transfusion may reduce mortality in patients with low Euroscore I risk. Clinically, these findings support an individualized transfusion approach, in which restrictive strategies may be appropriate for selected low-risk patients, while transfusion decisions in higher-risk patients should carefully balance potential gastrointestinal risks against the benefits of blood conservation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.